在超长时间窗口中,静脉静脉血栓溶解与tenecteplase的进展
Zhen Wang1,2, Hong-Jian Guan1, Lin-Zhuo Qu1
1Department of Neurology, the Affiliated Hospital of Yanbian University (Yanbian Hospital), Yanji, China.
Frontiers in neurology
|March 9, 2026
概括
甲 (TNK) 显示出延长缺血性中风患者治疗窗口长达24小时的前景. 虽然对再输血有效,但需要进一步的研究来确认其对患者长期预后的影响.
科学领域:
- 神经学 神经学
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 缺血性中风是全球主要的健康问题,传统的治疗方法受到狭窄的时间窗口的限制.
- 扩大治疗选择超出标准的4.5小时窗口对于改善患者的治疗结果至关重要.
- 一种较新的血栓解毒剂,即丁烯基酶 (TNK),在延长治疗时间方面具有潜在的优势.
研究的目的:
- 系统地审查最近关于使用Tenecteplase (TNK) 的超时窗血栓溶解的发现.
- 评估TNK在延长缺血性中风治疗窗口中的有效性和安全性.
- 确定未来研究领域,以优化超时窗血栓溶解策略.
主要方法:
- 系统审查最近的临床研究和对TNK的超时窗血栓溶解的试验.
- 分析了来自III期随机对照研究 (如ACT,TRACE-2,ORIGINAL) 和超时窗研究 (如TRACE-3,TIMELESS) 的数据.
- 审查研究TNK的安全性,反率和功能性结果的研究.
主要成果:
- 在4.5小时的窗口内,TNK与高高酶 (rt-PA) 不逊色,并且在大血管封闭中显示出优异的反.
- 超时窗研究表明,TNK具有积极的安全性概况,并改善了成像证实半阴影的选定患者 (4.5-24小时) 的功能结果.
- 一些研究表明,虽然超时窗血栓溶解可以改善再输血,但它可能无法持续改善患者的预后.
结论:
- 甲基酶 (TNK) 是缺血性中风中超时窗血栓溶解的有前途的药物,特别是在成像指导的情况下.
- 进一步的多中心试验是必要的,以优化治疗策略,可能包括神经保护剂和先进的成像.
- 在延长的时间窗口中,TNK在改善长期预后方面的作用需要继续调查.
相关概念视频
01:29Venous Thrombosis III: Interprofessional Care
433
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
433
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
578
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
578
01:16Clot Retraction and Fibrinolysis
9.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
9.8K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.2K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
01:30Acute Coronary Syndrome I: Introduction
1.3K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K